Early versus deferred antiretroviral therapy initiation and long-term cardiovascular disease outcomes in people with HIV: The START study - Quiz - MDSpire

Early versus deferred antiretroviral therapy initiation and long-term cardiovascular disease outcomes in people with HIV: The START study

  • By

  • Nila J Dharan

  • Shweta Sharma

  • Alejandro Arenas-Pinto

  • Daniel Duprez

  • Vicente Estrada

  • Karen Ha

  • Mariana Angelica Kundro

  • Rosie Mngqibisa

  • Henry Mugerwa

  • David Munroe

  • Rakan Nasreddine

  • Tess E Peterson

  • Irini Sereti

  • Janine M Trevillyan

  • Jason V Baker

  • Gail V Matthews

  • Andrew N Phillips

  • for the INSIGHT START Study Group

  • September 15, 2025

  • 0 min

Share

Original Source(s)

Early versus deferred antiretroviral therapy initiation and long-term cardiovascular disease outcomes in people with HIV: The START study

  • by Nila J Dharan, Shweta Sharma, Alejandro Arenas-Pinto, Daniel Duprez, Vicente Estrada, Karen Ha, Mariana Angelica Kundro, Rosie Mngqibisa, Henry Mugerwa, David Munroe, Rakan Nasreddine, Tess E Peterson, Irini Sereti, Janine M Trevillyan, Jason V Baker, Gail V Matthews, Andrew N Phillips, for the INSIGHT START Study Group

  • September 15, 2025

Related Content

Clinical Case Study: Post-Surgical Antiviral Intervention Following Pterygium Excision Informed by Corneal Confocal Microscopy

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

Immediate Two-Dimensional Angiographic Imaging of Cerebral Blood Flow